Activity

Filter

Cancel
Date Panel Item Activity
8 actions
Severe Combined Immunodeficiency (absent T absent B cells) v1.5 LCP2 Zornitza Stark Classified gene: LCP2 as Amber List (moderate evidence)
Severe Combined Immunodeficiency (absent T absent B cells) v1.5 LCP2 Zornitza Stark Gene: lcp2 has been classified as Amber List (Moderate Evidence).
Severe Combined Immunodeficiency (absent T absent B cells) v1.4 LCP2 Zornitza Stark edited their review of gene: LCP2: Added comment: PMID 36474126: 3-year-old child who was born to first-cousins parents and presented with recurrent infections, failure to thrive, and severe EBV-related infection and lymphoproliferation. Functional testing linking gene with impaired t cell signalling.; Changed rating: AMBER; Changed publications: 33231617, 36474126
Severe Combined Immunodeficiency (absent T absent B cells) v0.19 LCP2 Zornitza Stark Phenotypes for gene: LCP2 were changed from Severe combined immunodeficiency to Immunodeficiency 81, MIM# 619374; Severe combined immunodeficiency
Severe Combined Immunodeficiency (absent T absent B cells) v0.18 LCP2 Zornitza Stark edited their review of gene: LCP2: Changed phenotypes: Immunodeficiency 81, MIM# 619374, Severe combined immunodeficiency
Severe Combined Immunodeficiency (absent T absent B cells) v0.14 LCP2 Zornitza Stark Marked gene: LCP2 as ready
Severe Combined Immunodeficiency (absent T absent B cells) v0.14 LCP2 Zornitza Stark Gene: lcp2 has been classified as Red List (Low Evidence).
Severe Combined Immunodeficiency (absent T absent B cells) v0.14 LCP2 Zornitza Stark gene: LCP2 was added
gene: LCP2 was added to Severe Combined Immunodeficiency (absent T absent B cells). Sources: Literature
Mode of inheritance for gene: LCP2 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: LCP2 were set to 33231617
Phenotypes for gene: LCP2 were set to Severe combined immunodeficiency
Review for gene: LCP2 was set to RED
Added comment: Infant with bi-allelic variants in this gene and early-onset life-threatening infections, combined T and B cell immunodeficiency, severe neutrophil defects, and impaired platelet aggregation.
Sources: Literature